P rominent cell death unmatched by new cell generation is a hallmark of cardiomyopathy, acute myocardial injury and end-stage heart failure. The cumulative loss of myocytes in heart failure has generally been attributed to an apoptotic process, 1 which was thought to be the only form of programmed cell death. Although considerably less studied, necrosis may also be a critical mechanism underlying heart failure or occurring with aging.
Despite recent progress, the precise molecular mechanisms that determine the distinct cellular outcomes of TNFR1 signaling remain incompletely understood.
In this study, we identified TAK1 (encoded by the Map3k7 gene) as a nodal regulator of necroptotic cell death by functioning as a molecular switch in TNFR1 signaling. TAK1 was first identified as a transforming growth factor-β-activated kinase, but recent studies suggest that it is also activated by other inflammatory cytokines such as TNFα, interleukin-1, interleukin-18, and receptor activator of nuclear factor κB ligands. 10, 11 Importantly, TAK1 is activated in the mouse heart after pathological stress such as pressure overload and myocardial infarction, as well as in diseased human hearts. [12] [13] [14] Here, we show that cardiacspecific ablation of Map3k7 in mice promoted pathological remodeling, heart failure, and spontaneous death through the induction of apoptotic and necroptotic cell death. We also provide genetic evidence identifying TNFR1-mediated necroptotic signaling as the essential initiating event triggering adverse cardiac remodeling and heart failure in TAK1-deficient mice. Thus, regulation of necroptosis by TAK1 is critical for the maintenance of myocardial homeostasis and the prevention of pathological remodeling and heart failure progression.
Methods
An expanded Methods section is available in the online-only Data Supplement.
Animal Studies
The Map3k7 (TAK1) loxP-tageted mouse was described previously. 15 All procedures were approved and performed according to the guidelines of the Institutional Animal Care and Use Committees of the University of Washington.
Echocardiography, Transverse Aortic Constriction, and Plasma High-Mobility Group Box 1
Echocardiography was performed with a VisualSonics Vevo 2100 imaging system. Transverse aortic constriction was performed with a 27-or 28-gauge needle. Mouse plasma high-mobility group box 1 (HMGB1) levels were measured with an ELISA kit (Chondrex). 
Cell Lines

Statistics
An exact Wilcoxon rank-sum or Kruskal-Wallis test was used for studies with small sample sizes and when feasible for large sample sizes. Data with normal distribution were evaluated by 1-way ANOVA with the Bonferroni post hoc test or repeated measures ANOVA. Values of P<0.05 were considered statistically significant.
Results
TAK1 Is Essential for Cardiac Myocyte Survival and Myocardial Homeostasis
To study the function of TAK1 in the heart, we generated mice with cardiomyocyte-specific deletion of Map3k7 using a Cre/loxP-dependent conditional gene-targeting approach. Mice homozygous for the Map3k7-loxp (fl)-targeted allele (Map3k7fl/fl) 15 were crossed with several cardiomyocyte-specific Cre lines, including β-myosin heavy chain (MHC)-Cre, 16 αMHC-Cre, 17 and a tamoxifen-inducible αMHC-MerCreMer (MCM). 18 Western blot analysis showed that TAK1 was efficiently deleted (>90%) from the hearts of Map3k7fl/ fl-βMHC-Cre mice ( Figure 1A) . Strikingly, these TAK1-deleted mice showed a very severe phenotype with greatly reduced body weight and premature death by postnatal day 8 ( Figures 1B and 2D ). Masson trichrome staining of cardiac sections revealed massive focal and interstitial fibrosis, myocyte dropout, and myofiber disorganization ( Figure 1C and 1D). To study the function of TAK1 in the adult heart, we also crossed Map3k7fl/fl mice with the slightly later expressing αMHC-Cre line. Here, TAK1 was again efficiently deleted from the heart of Map3k7fl/fl-αMHC-Cre mice ( Figure 1E ), but these mice were viable as adults, although ≈30% died before 6 months of age. Histological analysis of cardiac sections of Map3k7fl/fl-αMHC-Cre mice again revealed high levels of myocardial fibrosis and cardiomyocyte dropout ( Figure 1F and 1G ). In addition, a significant increase in terminal deoxynucleotidyl transferase dUTP nick-end labelingpositive cells, cleaved caspase 3, and reactive oxygen species production was detected in cardiac sections of the TAK1-deficient mice ( Figure 1H and Figure IA and IB in the onlineonly Data Supplement), as well as increased plasma levels of HMGB1 ( Figure 1I ), which is a biomarker for necrotic cell death and myocardial infarction. 19, 20 Western blot analysis of the cleaved forms of caspase 8, caspase 3, and PARP (poly ADP ribose polymerase) showed greater caspase activation in the Map3k7-deficient heart compared with Map3k7fl/ fl controls ( Figure IC in the online-only Data Supplement). Intriguingly, Bnip3 (Bcl-2/adenovirus E1B 19 kDa proteininteracting protein 3), which has been implicated in regulating cardiac cell death and pathological remodeling, 21 was greatly upregulated in the absence of TAK1 ( Figure IC in the online-only Data Supplement). Taken together, these data indicate that loss of TAK1 promoted apoptotic and necrotic cell death in the heart.
Map3k7fl/fl-αMHC-Cre mice also showed significantly impaired cardiac function, ventricular dilation, and cardiac hypertrophy compared with littermate controls (Figure 1J-1M ). These results indicate that ablation of TAK1 promotes adverse ventricular remodeling and cardiac dysfunction, further suggesting a homeostatic role for TAK1 in the adult myocardium. We observed that TAK1 expression in the mouse heart was upregulated by mild pressure overload but downregulated by severe pressure overload ( Figure ID and IE in the online-only Data Supplement). This led us to investigate the role of TAK1 in regulating myocardial remodeling and heart failure propensity after pathological stimulation. Mice heterozygous for Map3k7-loxP allele by guest on http://circ.ahajournals.org/ Downloaded from December 9/16, 2014 with αMHC-Cre (Map3k7fl/ + αCre) were used to evaluate the role of TAK1 in pressure overload-induced cardiomyopathy. In contrast to the Map3k7fl/fl-αCre mice, Map3k7fl/ + αCre mice were overtly normal, with no signs of cardiac hypertrophy or cardiac dysfunction at baseline ( Figure II in the online-only Data Supplement). However, pressure overload stimulation uncovered a greater propensity for cardiac dysfunction and failure in Map3k7fl/ + αCre mice ( Figure II in the online-only Data Supplement). Thus, reduced TAK1 expression predisposed mice to cardiac dysfunction and failure after pressure overload stimulation, suggesting a critical cardioprotective role for TAK1 in response to pathological stress.
Ablation of TNFR1 Rescued Pathological Remodeling and Dysfunction of the TAK1-Deficient Heart
The TNFR1-mediated cell death pathway has been implicated in the pathogenesis of myocardial remodeling and heart failure. 22 Previous studies showed that TAK1 can be recruited to the TNFR1 complex where it regulates downstream signaling. 23 From these observations, we hypothesized that the TNFR1-mediated cell death pathway might account for the development of pathological remodeling and heart failure in Map3k7-deficient mice. To explore this, we crossed Tnfrsf1a −/− mice with Map3k7fl/fl-βCre mice. Remarkably, ablation of TNFR1 largely rescued the pathological phenotype of Map3k7fl/fl-βCre mice by preventing widespread myocyte dropout and subsequent cardiac fibrosis, retarded growth, and premature death (Figure 2A-2D ). In addition, we crossed Tnfrsf1a −/− mice with Map3k71fl/ fl-αCre mice to generate the Tnfrsf1a −/− Map3k7fl/fl-αCre mice for functional analysis of the adult heart. Map3k7fl/ fl-αCre mice in the Tnfsrf1a −/− background showed better contractile function, less cardiac hypertrophy, and less ventricular dilation compared with Map3k7fl/fl-αCre mice in the Tnfrsf1a + / + background ( Figure 2E-2H ). These data suggest that TNFR1 signaling plays a critical role in the pathogenesis of adverse cardiac remodeling and dysfunction associated with TAK1 deficiency. 
TAK1 Is a Nodal Regulator of TNFR1-Mediated Necroptosis
On the basis of the data presented above, we further hypothesized that deletion of TAK1 triggers adverse cardiac remodeling and heart failure by promoting TNFR1-mediated cell death signaling. To test this hypothesis, we assessed whether TAK1 directly regulates cardiac myocyte survival/death. Rat neonatal cardiomyocytes were infected with an adenovirus encoding the dominant-negative TAK1 (AdTAK1-KW) to inhibit endogenous TAK1 activity or with a control adenovirus expressing β-galactosidase (Ad-βgal), followed by TNFα stimulation. TNFα induced rapid cell death with propidium iodide uptake in Ad-TAK1-KW-infected myocytes but not in Ad-βgal-infected myocytes ( Figure 3A ). This effect was largely blocked by the RIP1 kinase inhibitor necrostatin-1 (Nec-1) 24 but not by z-VAD-fmk (zVAD), a broad-spectrum caspase inhibitor. Thus, inactivation of TAK1 promoted TNFα-induced myocyte death through an RIP1-dependent but caspase-independent mechanism, suggesting the induction of necroptosis. Moreover, Western blot analysis revealed that inactivation of TAK1 by AdTAK1-KW infection promoted the cleavage of PARP, caspase 8, and caspase 3 in cardiac myocytes after TNFα stimulation ( Figure 3B ). Importantly, HMGB1, a biomarker for necrosis, was readily detectable in the culture supernatants of Ad-TAK1-KW-infected cells following TNFα stimulation for 2 hours ( Figure 3B ). These results indicate that inhibition of TAK1 promotes both apoptotic and necroptotic signaling. Furthermore, inactivation of TAK1 also abolished TNFα-stimulated c-Jun N-terminal kinase phosphorylation and transient IκBα degradation in cardiac myocytes ( Figure 3B ). These data suggest that TAK1 is essential for the activation of c-Jun N-terminal kinase and NFκB, both of which have been implicated in the regulation of cell survival and death.
Consistent with our results in cardiomyocytes, deletion of TAK1 (Map3k7) in MEFs also promoted cell death on TNFα stimulation ( Figure 3C ). Importantly, reconstitution of Map3k7 −/− MEFs with wild-type TAK1, but not TAK1-KW, prevented TNFα-induced cell death. These results further confirm that TAK1 kinase activity is essential for cell survival in response to TNFα stimulation. To further investigate the role of TAK1 in TNFα signaling, wild-type MEFs were treated with 5Z-7-oxozeanol (5z-7), 25 a selective inhibitor for TAK1, in the presence or absence of Nec-1 or zVAD. Western blot analysis showed that inhibition of TAK1 with Figure 3D ). These effects were reversed by the RIP1 inhibitor Nec-1, suggesting that RIP1 is a key regulator for both apoptotic and necroptotic signaling in the setting of TAK1 inhibition. Intriguingly, although zVAD efficiently blocked the cleavage of PARP, caspase 3, and CYLD, a significant loss of full-length RIP1, RIP3, and FLIP was still observed. Importantly, zVAD failed to block the necrotic HMGB1 release. Therefore, protein cleavage, a key event in apoptosis, does not necessarily put necroptosis in check under certain conditions. Finally, we confirmed that TAK1 regulates TNFα-mediated cell death through TNFR1 (Tnfrsf1a) but not TNFR2 (Tnfrsf1b; Figure III in the online-only Data Supplement).
TAK1 Regulates TNFR1-Mediated Necroptosis via RIP1-Fadd-Caspase 8
Several signaling molecules of extrinsic and intrinsic cell death pathways such as RIP1, caspase 8, FADD, and cyclophilin D have been implicated as key mediators in TNFα-induced cell death. [26] [27] [28] [29] Here, we assessed their roles in TAK1-regulated cell death using specific gene-deleted MEFs. Costimulation with TNFα and 5z-7 induced rapid necroptotic cell death in wild-type MEFs, which was largely blocked by deletion of RIP1 (Ripk1), FADD (Fadd), or caspase 8 (casp8) but not by cyclophilin D (Ppif; Figure 4A ). These results suggest that TAK1 regulates necroptosis through an RIP1/FADD/caspase 8-dependent, but cyclophillin D-independent, mechanism. To further assess the role of caspase 8 in necroptosis associated with TAK1 inhibition, we reconstituted casp8 −/− MEFs with wild-type caspase 8, a C360A mutant (without proteolytic activity), or an empty vector. Importantly, reconstitution of casp8 −/− MEFs with wild-type caspase 8 or C360A mutant restored the necroptotic response, whereas casp8 −/− cells containing the empty vector were unable to undergo necroptosis ( Figure IV in the online-only Data Supplement). These data suggest a new role for caspase 8 by functioning as a scaffolding molecule in necroptotic signaling.
Next, we assessed how FADD, caspase 8, and RIP1 affect apoptotic and necroptotic signaling. Costimulation with TNFα and 5z-7, but not TNFα alone, induced PARP and caspase 8 cleavage, as well as HMGB1 release, in wild-type MEFs ( Figure 4B-4D) . Importantly, these effects were largely abolished in Fadd −/− or casp8 −/− MEFs, suggesting that both FADD and caspase 8 are required for apoptotic and necroptotic signaling in the setting of TAK1 inhibition ( Figure 4B and 4C). Interestingly, deletion of RIP1 blocked HMGB1 release but not PARP or caspase 8 cleavage ( Figure 4D ). Of note, TNFα alone was able to induce PARP and caspase 8 cleavage in Ripk1 −/− MEFs but not HMGB1 release. Thus, Ad-βgal Ad-TAK1
Ad-TAK1-KW deletion of RIP1 inhibits necroptosis but promotes apoptosis, indicating that RIP1 plays distinct roles in apoptotic and necroptotic signaling.
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To initiate cell death, RIP1 must dissociate from the TNFR1 complex and bind to FADD and caspase 8 to form a cell death-inducing complex (called complex II). We next determined whether and how TAK1 regulates complex II formation by immunoprecipitation. As expected, no association of FADD with either RIP1 or caspase 8 was detected in cardiomyocytes treated with vehicle control, 5z-7 alone, or TNFα alone ( Figure 4E ). However, coimmunoprecipitation of both RIP1 and caspase 8 with FADD was observed in cells treated with 5z-7 plus TNFα, suggesting that inhibition of TAK1 promotes RIP1-FADD-caspase 8 complex formation ( Figure 4E ). An anti-cleaved caspase 8 antibody was used to recognize mainly the p43 fragment because pro-caspase 8 migrated at the same mobility as the IgG heavy chain from the FADD immunoprecipitates, precluding the detection of uncleaved pro-caspase 8 by Western blotting. Also of note, cleavage of RIP1, caspase 8, and FADD was detected on treatment with 5z-7 plus TNFα, suggesting the induction of an active complex II ( Figure 4E ).
We then asked whether activation of TAK1 could inhibit the RIP1/FADD/caspase 8 interaction under necroptosisinducing conditions. Cardiomyocytes were infected with adenoviruses encoding a constitutively active mutant TAK1ΔN, TAK1 plus its activator TAB1, or Adβgal control, followed by stimulation with TNFα, cycloheximide, and zVAD. Consistent with previous observations, 30 cleaved caspase 8 was detectable in the Fadd immunoprecipitates because zVAD failed to block the cleavage of caspase 8 into the p43 fragment ( Figure 4F ). Importantly, overexpression of TAK1ΔN, or TAK1 plus TAB1, largely blocked the Fadd-RIP1-caspase 8 interaction induced by the combination of TNFα, cycloheximide, and zVAD ( Figure 4F ). These data strongly suggest that TAK1 functions as a key regulator in TNFα-mediated cell death signaling by specifically blocking the RIP1-FADD-caspase 8 cell deathinducing complex.
To gain further insight into the regulatory mechanism underlying this observation, we determined that TNFα stimulation promoted rapid association of TAK with RIP1 ( Figure 4G ). Intriguingly, this association was abolished by inhibition of TAK1 with 5z-7 ( Figure 4G ). Moreover, TAK1 phosphorylation and ubiquitination induced by TNFα were also blocked by 5z-7 ( Figure 4H ). These data suggest that TAK1 phosphorylation and ubiquitination are critical for the RIP1-TAK1 interaction. From these data, we propose that activation of TAK1 promotes its association with RIP1, thus preventing the interaction of RIP1 with other cell death-signaling proteins, including FADD and caspase 8. On the other hand, inhibition of TAK1 disrupts its association with RIP1, leading to a switch of RIP1-binding partners and the induction of the RIP1-FADD-caspase 8 complex. Therefore, TAK1 functions as a molecular switch in TNFR1-mediated cell survival and death signaling.
TAK1 Regulates the RIP1-RIP3 Interaction Through Fadd and Caspase 8
Induction of necroptosis relies on the interaction of RIP1 and RIP3 through the homotypic interaction motif and the formation of the necroptosis complex. [5] [6] [7] Here, we assessed whether TAK1 exerts its effect on necroptotic signaling by regulating the RIP1-RIP3 interaction. Indeed, the RIP1-RIP3 interaction was detected in cells treated with TNFα and 5z-7 ( Figure 5A ). Nec-1, but not zVAD, efficiently blocked the RIP1-RIP3 interaction, suggesting that RIP1 kinase activity, but not caspase activity, is required in this process ( Figure 5A ). Importantly, no RIP1-RIP3 interaction was detected in Fadd −/− or casp8 −/− MEFs after treatment with 5z-7 plus TNFα ( Figure 5B and 5C ). Therefore, both FADD and caspase 8 are required in TAK1-mediated molecular regulation of RIP1-RIP3 necrosome formation.
To determine the role of RIP3 in TNFα-induced cell death in the setting of TAK1 inhibition, we infected cardiomyocytes with adenoviral vectors encoding RIP3 shRNA or a scrambled sequence. RIP3 silencing largely abolished HMGB1 release and necroptic cell death induced by 5z-7 and TNFα but had no effects on the cleavage of PARP and caspase 8 ( Figure 5D-5F ). Similar effects were observed in Ripk3 −/− MEFs ( Figure V in the online-only Data Supplement). These data suggest that RIP3 is a dedicated regulator of TNFα-induced necroptosis, but not apoptosis, in the setting of TAK1 inhibition. Interestingly, loss of RIP3 mildly enhanced apoptosis, which was blocked by zVAD ( Figure 5G ). Moreover, zVAD further increased HMGB1 release and necroptosis, which were blocked by RIP3 silencing ( Figure 5D-5F ). Taken together, these data suggest that RIP1 is involved in both apoptosis and necroptosis in the setting of TAK1 inhibition, whereas RIP3 is a dedicated regulator of necroptosis.
Blockade of Necroptosis Prevents Pathological Remodeling and Heart Failure in TAK1-Deficient Mice
To fully assess the role of TAK1 in adult mice, we used a tamoxifen-inducible Cre-mediated recombination system for acute deletion of Map3k7 in the heart. Map3k7fl/fl mice were crossed with MCM transgenic mice, which in the absence of tamoxifen were overtly normal with no detectable phenotype at baseline (data not shown). After tamoxifen treatment, TAK1 was efficiently deleted from the hearts of Map3k7fl/ fl-MCM mice but not Map3k7fl/fl or MCM control mice ( Figure 6A ). Strikingly, Map3k7fl/fl-MCM mice developed severe cardiac dysfunction, ventricular dilation, and hypertrophy 2 week after tamoxifen administration ( Figure 6B-6D ). This was associated with a marked increase in plasma HMGB1 and cardiac fibrosis, indicating that cardiac necrosis and pathological remodeling were induced by acute deletion of Map3k7 in the adult myocardium ( Figure 6E-6G) . To test the hypothesis that the pathological cardiac phenotype associated with TAK1 deficiency is due to necroptotic myocyte death, Map3k7fl/fl-MCM and control mice were treated with the RIP1 inhibitor Nec-1 or vehicle control, along with tamoxifen. Remarkably, administration of Nec-1 largely rescued cardiac dysfunction, ventricular dilation, and hypertrophy in Map3k7fl/fl-MCM mice ( Figure 6B-6D ). Necrotic HMGB1 release and cardiac fibrosis in the TAK1-deficient mice were also largely abolished by Nec-1 ( Figure 6E-6G) . These data further suggest that myocardial necroptosis is a critical initiating event in the pathogenesis of cardiac dysfunction and remodeling in Map3k7-deficient mice. Moreover, these results also validate RIP1 as a therapeutic target for heart failure by demonstrating that inhibition of RIP1 by Nec-1 prevented myocyte death, pathological remodeling, and heart failure progression in a mouse model of myocardial necroptosis in vivo.
Discussion
TAK1 signaling is essential for regulating a number of important biological processes, including immune cell activation, inflammation, cell differentiation, and cardiac hypertrophic growth. 6, 31 The present study uncovers a previously unrecognized biological function for TAK1 in regulating myocardial survival/death and cardiac homeostasis. Consistent with our findings, ablation of TAK1 in noncardiac tissues, including skin, intestine, and liver, resulted in spontaneous cell death, inflammation, and fibrosis. [32] [33] [34] However, the mechanism underlying this protective role of TAK1 was not identified in those earlier studies. Here, we demonstrate that TAK1 functions as nodal regulator of TNFR1-mediated apoptotic and necroptotic cell death-signaling pathways ( Figure 6H ). Under normal conditions, ligation of TNFR1 promotes the association of TAK1 with RIP1, which prevents RIP1-FADD-caspase 8 cell death complex formation. This is associated with the activation of the downstream IκB kinase-NFκB prosurvival pathway ( Figure 6H ). However, with low or inhibited TAK1 activity, RIP1 dissociates from TAK1 and switches its interacting partners to bind caspase 8 and FADD. The induction of the RIP1-FADD-caspase 8 and RIP1-RIP3 complexes leads to necroptotic cell death ( Figure 6H ). In addition, blockade of the IκB kinase-NFκB prosurvival pathway may represent another switch for cell death induction at low TAK1 activity.
In mice, TAK1 expression is relatively high in embryonic and neonatal myocardium and gradually becomes downregulated toward adulthood. 6 We observed that TAK1 expression in the mouse heart was upregulated by mild pressure overload but downregulated by severe pressure overload ( Figure  I in the online-only Data Supplement). Upregulation of TAK1 seems to represent an important adaptive mechanism under pathological conditions because TAK1-deficient mice are predisposed to adverse cardiac remodeling and heart failure after pressure overload. In addition, by using an inducible transgenic mouse model expressing active TAK1ΔN, we observed that activation of TAK1 in the adult mice prevented heart failure progression after myocardial infarction (Y.C., L.L., and Q.L., unpublished observations). However, conventional transgenic mice with extensive overexpression of TAK1ΔN died within 2 weeks of birth with hypertrophic cardiomyopathy, 6 suggesting that the timing and extent of TAK1 activation are critical in determining its biological effects in the heart.
Our data indicate that TAK1 also regulates the IκB kinase-NFκB prosurvival pathway in cardiac myocytes. In contrast to the severe cardiac phenotype observed in our TAK1-deficient mice, cardiac-specific ablation of RelA (NFκB-p65) did not show cardiac abnormalities. 35 Similarly, mice lacking Nfkb1 (NFκB-p50) exhibited no detectable cardiac phenotype at baseline and even showed protection against myocardial ischemic injury. 36 In line with this, it has been shown that TAK1 can regulate cell death in an NFκB-independent manner. 37 These observations suggest that although NFκB is potentially important in regulating myocardial survival and death, TAK1 is more critical in determining cell fate by functioning as a molecular switch in determining outcomes of TNFα signaling (prosurvival or prodeath effects). 22, 38 Although initially thought to constitute mutually exclusive cellular states, we provide evidence that apoptosis and necroptosis can coexist under certain cell death-inducing conditions. Moreover, we showed that death receptormediated apoptosis and necroptosis share some common signaling components. Our data revealed that FADD, RIP1, and caspase-8 are common signaling components for apoptosis and necroptosis under certain conditions. Indeed, we observed that genetic deletion of Fadd or caspase 8 prevented RIP1-RIP3 interaction and necroptotic cell death in TAK1-deficient cells. Whether FADD is strictly required for the formation of the necroptotic complex has been controversial. 28, [39] [40] [41] We demonstrate that Fadd is crucial for both apoptotic and necroptotic signaling through regulation of 2 cell death-inducing complexes (ie, RIP1-FADD-caspase 8 and RIP1-RIP3). Similarly, the role of caspase 8 in necroptosis has not been unequivocally established. 28, [42] [43] [44] [45] Our results suggest a new model whereby caspase 8 functions as a scaffold molecule in transducing necroptotic signaling independently of its proteolytic activity under certain cell death-inducing conditions such as TAK1 inhibition.
There is a lack of mechanistic data implicating necroptotic cell death as a significant contributor to heart failure, although correlative data have been shown. Here, we provide an in vivo experimental paradigm that regulation of necroptosis by TAK1 is critical for the maintenance of myocardial homeostasis and the prevention of pathological remodeling and heart failure progression. Our data also suggest that the TAK1 signaling pathway and its effectors may serve as new therapeutic targets for treating heart failure. For instance, we showed that overexpression of TAK1ΔN or TAK1-TAB1 prevented necroptosis signaling in cardiac myocytes. Moreover, on the basis of our observations that FADD and caspase 8 are critical for both apoptotic and necroptotic signaling, it will be important to further evaluate the therapeutic potential of FADD or caspase 8 in experimental models of heart disease. Finally, we demonstrated that inhibition of RIP1 by Nec-1 blocked necroptotic cell death in cardiac myocytes and rescued pathological remodeling and heart failure in a mouse model of myocardial necroptosis in vivo. Nec-1 has also been shown to reduce ischemic injuries in the heart and brain. 24, 46 These results suggest that inhibition of RIP1 may have widespread clinical utility for a range of pathological conditions involving cell death.
SUPPLEMENTAL MATERIAL Expanded Methods
Reagents 5z-7-oxozeaenol, cycloheximide, necrostatin-1, and tamoxifen were purchased from Sigma. Mouse TNFα was from R&D Systems. zVad-FMK and z-IETD-FMK were obtained from Abcam. Propidium iodide, Hoechst 33342, and G418 were from Invitrogen. pcDNA3-casp8 and pcDNA3-casp8 C360A constructs were obtained from Addgene.
Animal models
The generation of Map3k7 (TAK1) loxP-tageted (fl) mice, in which exon 2 (encoding the ATP-binding site) was flanked by loxP, was described previously 15 . 
Echocardiography, TAC, and plasma HMGB1
For echocardiography, mice were anesthetized with 2% isoflurane by inhalation and scanning was performed with a VisualSonics Vevo 2100 imaging system as described previously 35 . M-mode left ventricular dimensions were averaged from 3-5 beats. Fractional shortening was calculated as described previously 35 . Transverse aortic constriction (TAC) was performed to produce cardiac pressure overload in mice using a 27-gauge needle as previously described 47 . Sham-operated mice underwent the same procedure without constriction. Pressure gradients (PG; mm Hg) across the aortic constriction were 
